论文部分内容阅读
本文对100例胆道系统感染病人其中50例采用先锋必治疗,50例采用氨基苷类抗生素治疗,进行对比观察先锋必组治愈率为62%,显效率为90%明显优于对照组。另先锋必不良反应发生率仅为6%。先锋必以其广谱、高效、胆汁浓度高、肝肾功能不全时不需调整正常剂量及副作用小、价格低廉宜选为临床治疗胆道系统感染一线药物,尤其对70岁以上老年病人或伴有肝肾功能不全的胆道系统感染病人,更应将先锋必作为首选药物。
In this paper, 100 cases of patients with biliary tract infection in which Pioneer will be treated in 50 cases, 50 cases treated with aminoglycoside antibiotics, Pneumoconiosis group compared the cure rate was 62%, 90% was significantly better than the control group. Another pioneer adverse reaction rate was only 6%. Pioneer will be its broad-spectrum, high efficiency, high bile concentrations, liver and kidney dysfunction without the need to adjust the normal dose and side effects, low prices should be selected for clinical treatment of first-line drugs in the biliary system infection, especially for elderly patients over the age of 70 or with Liver and kidney dysfunction in patients with biliary tract infections, but should be the pioneer will be the drug of choice.